BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 15826992)

  • 1. Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus.
    Sprenger A; Zils E; Rambold H; Sander T; Helmchen C
    Ann N Y Acad Sci; 2005 Apr; 1039():395-403. PubMed ID: 15826992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
    Kalla R; Glasauer S; Büttner U; Brandt T; Strupp M
    Brain; 2007 Sep; 130(Pt 9):2441-51. PubMed ID: 17664175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of the gravity dependence of downbeat nystagmus with 3,4-diaminopyridine.
    Sprenger A; Rambold H; Sander T; Marti S; Weber K; Straumann D; Helmchen C
    Neurology; 2006 Sep; 67(5):905-7. PubMed ID: 16966567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
    Kalla R; Spiegel R; Claassen J; Bardins S; Hahn A; Schneider E; Rettinger N; Glasauer S; Brandt T; Strupp M
    J Neuroophthalmol; 2011 Dec; 31(4):320-5. PubMed ID: 21734596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 3,4-diaminopyridine on the gravity dependence of ocular drift in downbeat nystagmus.
    Helmchen C; Sprenger A; Rambold H; Sander T; Kömpf D; Straumann D
    Neurology; 2004 Aug; 63(4):752-3. PubMed ID: 15326263
    [No Abstract]   [Full Text] [Related]  

  • 6. Modelling drug modulation of nystagmus.
    Glasauer S; Rössert C
    Prog Brain Res; 2008; 171():527-34. PubMed ID: 18718349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminopyridines for the treatment of cerebellar and ocular motor disorders.
    Strupp M; Kalla R; Glasauer S; Wagner J; Hüfner K; Jahn K; Brandt T
    Prog Brain Res; 2008; 171():535-41. PubMed ID: 18718350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
    Tsunemi T; Ishikawa K; Tsukui K; Sumi T; Kitamura K; Mizusawa H
    J Neurol Sci; 2010 May; 292(1-2):81-4. PubMed ID: 20181362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
    Strupp M; Schüler O; Krafczyk S; Jahn K; Schautzer F; Büttner U; Brandt T
    Neurology; 2003 Jul; 61(2):165-70. PubMed ID: 12874393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional MRIs disclose cerebellar pathologies in idiopathic downbeat nystagmus.
    Hüfner K; Stephan T; Kalla R; Deutschländer A; Wagner J; Holtmannspötter M; Schulte-Altedorneburg G; Strupp M; Brandt T; Glasauer S
    Neurology; 2007 Sep; 69(11):1128-35. PubMed ID: 17846412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
    Feil K; Claaßen J; Bardins S; Teufel J; Krafczyk S; Schneider E; Schniepp R; Jahn K; Kalla R; Strupp M
    Neurology; 2013 Sep; 81(13):1152-8. PubMed ID: 23975871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gravity dependence of ocular drift in patients with cerebellar downbeat nystagmus.
    Marti S; Palla A; Straumann D
    Ann Neurol; 2002 Dec; 52(6):712-21. PubMed ID: 12447924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium channels, the cerebellum, and treatment for downbeat nystagmus.
    Leigh RJ
    Neurology; 2003 Jul; 61(2):158-9. PubMed ID: 12874391
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus.
    Glasauer S; Strupp M; Kalla R; Büttner U; Brandt T
    Ann N Y Acad Sci; 2005 Apr; 1039():528-31. PubMed ID: 15827015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postural Ataxia in Cerebellar Downbeat Nystagmus: Its Relation to Visual, Proprioceptive and Vestibular Signals and Cerebellar Atrophy.
    Helmchen C; Kirchhoff JB; Göttlich M; Sprenger A
    PLoS One; 2017; 12(1):e0168808. PubMed ID: 28056109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 4-aminopyridine on gravity dependence and neural integrator function in patients with idiopathic downbeat nystagmus.
    Sander T; Sprenger A; Marti S; Naumann T; Straumann D; Helmchen C
    J Neurol; 2011 Apr; 258(4):618-22. PubMed ID: 21057959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.
    Kalla R; Glasauer S; Schautzer F; Lehnen N; Büttner U; Strupp M; Brandt T
    Neurology; 2004 Apr; 62(7):1228-9. PubMed ID: 15079036
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognosis of idiopathic downbeat nystagmus.
    Wagner J; Lehnen N; Glasauer S; Strupp M; Brandt T
    Ann N Y Acad Sci; 2009 May; 1164():479-81. PubMed ID: 19645953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smooth pursuit in patients with downbeat nystagmus.
    Glasauer S; Hoshi M; Büttner U
    Ann N Y Acad Sci; 2005 Apr; 1039():532-5. PubMed ID: 15827016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upbeat about downbeat nystagmus.
    Halmagyi GM; Leigh RJ
    Neurology; 2004 Aug; 63(4):606-7. PubMed ID: 15326227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.